ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
203 EUR
+2 (+1%)
Taking everything into account, 1ABBV scores 5 out of 10 in our fundamental rating. 1ABBV was compared to 78 industry peers in the Biotechnology industry. There are concerns on the financial health of 1ABBV while its profitability can be described as average. 1ABBV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
1ABBV had positive earnings in the past year.
In the past year 1ABBV had a positive cash flow from operations.
Each year in the past 5 years 1ABBV has been profitable.
1ABBV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.71%, 1ABBV is in the better half of the industry, outperforming 76.62% of the companies in the same industry.
With an excellent Return On Invested Capital value of 13.81%, 1ABBV belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
1ABBV had an Average Return On Invested Capital over the past 3 years of 13.67%. This is in line with the industry average of 12.34%.
The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(13.81%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROIC | 13.81% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
1ABBV has a better Profit Margin (6.38%) than 80.52% of its industry peers.
1ABBV's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 31.27%, 1ABBV belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
In the last couple of years the Operating Margin of 1ABBV has declined.
1ABBV has a better Gross Margin (70.93%) than 64.94% of its industry peers.
In the last couple of years the Gross Margin of 1ABBV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ABBV is still creating some value.
The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
1ABBV has more shares outstanding than it did 5 years ago.
1ABBV has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.40 indicates that 1ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
1ABBV's Altman-Z score of 2.40 is fine compared to the rest of the industry. 1ABBV outperforms 63.64% of its industry peers.
1ABBV has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as 1ABBV would need 3.86 years to pay back of all of its debts.
1ABBV's Debt to FCF ratio of 3.86 is fine compared to the rest of the industry. 1ABBV outperforms 79.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 2.4 |
ROIC/WACC1.52
WACC9.09%
2.3 Liquidity
A Current Ratio of 0.74 indicates that 1ABBV may have some problems paying its short term obligations.
1ABBV's Current ratio of 0.74 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 76.62% of its industry peers.
1ABBV has a Quick Ratio of 0.74. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
1ABBV's Quick ratio of 0.61 is on the low side compared to the rest of the industry. 1ABBV is outperformed by 77.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 |
3. Growth
3.1 Past
The earnings per share for 1ABBV have decreased by -1.03% in the last year.
1ABBV shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.51% yearly.
The Revenue has been growing slightly by 6.05% in the past year.
1ABBV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.11% yearly.
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
3.2 Future
The Earnings Per Share is expected to grow by 13.59% on average over the next years. This is quite good.
Based on estimates for the next years, 1ABBV will show a small growth in Revenue. The Revenue will grow by 7.22% on average per year.
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 22.26 indicates a rather expensive valuation of 1ABBV.
Based on the Price/Earnings ratio, 1ABBV is valued cheaper than 80.52% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1ABBV to the average of the S&P500 Index (25.65), we can say 1ABBV is valued inline with the index average.
The Price/Forward Earnings ratio is 16.21, which indicates a correct valuation of 1ABBV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1ABBV indicates a rather cheap valuation: 1ABBV is cheaper than 87.01% of the companies listed in the same industry.
1ABBV is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.45, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.26 | ||
| Fwd PE | 16.21 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1ABBV is valued a bit cheaper than the industry average as 77.92% of the companies are valued more expensively.
1ABBV's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1ABBV is cheaper than 84.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.83 | ||
| EV/EBITDA | 17.28 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ABBV does not grow enough to justify the current Price/Earnings ratio.
1ABBV has a very decent profitability rating, which may justify a higher PE ratio.
1ABBV's earnings are expected to grow with 16.85% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.6
PEG (5Y)8.87
EPS Next 2Y19.88%
EPS Next 3Y16.85%
5. Dividend
5.1 Amount
1ABBV has a Yearly Dividend Yield of 2.87%. Purely for dividend investing, there may be better candidates out there.
1ABBV's Dividend Yield is rather good when compared to the industry average which is at 12.49. 1ABBV pays more dividend than 94.81% of the companies in the same industry.
1ABBV's Dividend Yield is comparable with the S&P500 average which is at 2.41.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
5.2 History
On average, the dividend of 1ABBV grows each year by 7.72%, which is quite nice.
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1ABBV pays out 304.54% of its income as dividend. This is not a sustainable payout ratio.
The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP304.54%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
BIT:1ABBV (11/24/2025, 7:00:00 PM)
203
+2 (+1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners74.42%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap358.61B
Revenue(TTM)58.33B
Net Income(TTM)3.72B
Analysts79.46
Price Target197.82 (-2.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.87% |
Yearly Dividend5.38
Dividend Growth(5Y)7.72%
DP304.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.04%
Min EPS beat(2)0.95%
Max EPS beat(2)1.14%
EPS beat(4)4
Avg EPS beat(4)0.75%
Min EPS beat(4)0.02%
Max EPS beat(4)1.14%
EPS beat(8)7
Avg EPS beat(8)0.76%
EPS beat(12)9
Avg EPS beat(12)0.46%
EPS beat(16)11
Avg EPS beat(16)0.4%
Revenue beat(2)2
Avg Revenue beat(2)0.93%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.23%
Revenue beat(4)2
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.36%
Revenue beat(12)5
Avg Revenue beat(12)-0.32%
Revenue beat(16)5
Avg Revenue beat(16)-0.81%
PT rev (1m)4.92%
PT rev (3m)5.18%
EPS NQ rev (1m)-45.1%
EPS NQ rev (3m)-44.14%
EPS NY rev (1m)-12.38%
EPS NY rev (3m)-13.98%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.26 | ||
| Fwd PE | 16.21 | ||
| P/S | 7.14 | ||
| P/FCF | 22.83 | ||
| P/OCF | 21.6 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.28 |
EPS(TTM)9.12
EY4.49%
EPS(NY)12.52
Fwd EY6.17%
FCF(TTM)8.89
FCFY4.38%
OCF(TTM)9.4
OCFY4.63%
SpS28.43
BVpS-0.09
TBVpS-45.26
PEG (NY)3.6
PEG (5Y)8.87
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | N/A | ||
| ROCE | 18.72% | ||
| ROIC | 13.81% | ||
| ROICexc | 14.74% | ||
| ROICexgc | 370.81% | ||
| OM | 31.27% | ||
| PM (TTM) | 6.38% | ||
| GM | 70.93% | ||
| FCFM | 31.27% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 2.58 | ||
| Cap/Depr | 12.62% | ||
| Cap/Sales | 1.79% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 72.74% | ||
| Profit Quality | 489.9% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.61 | ||
| Altman-Z | 2.4 |
F-Score6
WACC9.09%
ROIC/WACC1.52
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.03%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%12.08%
EPS Next Y6.19%
EPS Next 2Y19.88%
EPS Next 3Y16.85%
EPS Next 5Y13.59%
Revenue 1Y (TTM)6.05%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%6.65%
Revenue Next Year8.23%
Revenue Next 2Y8.64%
Revenue Next 3Y8.27%
Revenue Next 5Y7.22%
EBIT growth 1Y13.81%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year20.95%
EBIT Next 3Y15.22%
EBIT Next 5Y11.27%
FCF growth 1Y-26.45%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-24.5%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
Can you provide the valuation status for ABBVIE INC?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for 1ABBV stock?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 22.26 and the Price/Book (PB) ratio is -2275.52.
Can you provide the financial health for 1ABBV stock?
The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.